Patents Assigned to Destiny Pharma Limited
  • Methods of inhibiting microbial biofilms
    Patent number: 9326511
    Abstract: The invention provides the use of a compound of formula (I), or metallated derivative thereof, for killing, inhibiting or preventing the growth of a microbial biofilm: wherein X1, X2, X3, X4, Y1, Y2, Y3, Y4 and Z have meanings given in the description. The biofilm may be on a living or inert support. Preferably, the microorganisms are selected from the group consisting of bacteria and fungi.
    Type: Grant
    Filed: October 23, 2009
    Date of Patent: May 3, 2016
    Assignee: Destiny Pharma Limited
    Inventors: William Guy Love, William Rhys-Williams
  • Porphyrin derivatives and their use in photodynamic therapy
    Patent number: 8084602
    Abstract: A compound of formula I: wherein X1, X2, X3, X4, Y1, Y2, Y3, Y4 and Z have meanings given in the description, and metallated forms of such compounds, which are useful in the treatment of medical conditions for which a photodynamic compound is indicated. Pharmaceutical formulations and methods of treatment of a medical condition for which a photodynamic agent is indicated are also disclosed. Sterilizing solutions comprising a compound of the invention, and the use thereof, are also disclosed.
    Type: Grant
    Filed: November 21, 2006
    Date of Patent: December 27, 2011
    Assignee: Destiny Pharma Limited
    Inventors: William Love, Derek Brundish, William Rhys-Williams, Xiang Dong Feng, Benoit Pugin
  • Porphyrin derivatives and their use in photodynamic therapy
    Patent number: 7244841
    Abstract: A compound of formula I: wherein X1, X2, X3, X4, Y1, Y2, Y3, Y4 and Z have meanings given in the description, and metallated forms of such compounds, which are useful in the treatment of medical conditions for which a photodynamic compound is indicated. Pharmaceutical formulations and methods of treatment of a medical condition for which a photodynamic agent is indicated are also disclosed. Sterilizing solutions comprising a compound of the invention, and the use thereof, are also disclosed.
    Type: Grant
    Filed: December 23, 2003
    Date of Patent: July 17, 2007
    Assignees: Destiny Pharma Limited, Solvias AG
    Inventors: William Love, Derek Brundish, William Rhys-Williams, Xiang Dong Feng, Benoit Pugin
  • Phospholipid-coated implants
    Patent number: 6863693
    Abstract: A prosthesis or implant has a surface carrying a coating comprising at least one phospholipid at a concentration to improve osteointegration. A method of making such a prosthesis or implant and a kit comprising a prosthesis or implant is also described.
    Type: Grant
    Filed: February 28, 2002
    Date of Patent: March 8, 2005
    Assignees: Destiny Pharma Limited, University of Brighton
    Inventors: Andrew W. Lloyd, Matteo Santin, Stephen P. Denyer, William Rhys-Williams, William G. Love
  • Novel compounds and uses thereof
    Publication number: 20040143001
    Abstract: A compound of formula I: 1
    Type: Application
    Filed: December 23, 2003
    Publication date: July 22, 2004
    Applicants: Destiny Pharma Limited, Solvias AG
    Inventors: William Love, Derek Brundish, William Rhys-Williams, Xiang Dong Feng, Benoit Pugin
  • Porphyrin derivatives their use in photodynamic therapy and medical devices containing them
    Patent number: 6630128
    Abstract: There is provided a compound of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X, Y1, Y2, Y3, Z, M, A-B and C-D have meanings given in the description, which are useful in the treatment of medical conditions for which a photodynamic compound is indicated. Compositions, apparatus and methods of treatment of a medical condition for which a photodynamic compound is indicated are also disclosed.
    Type: Grant
    Filed: April 30, 2001
    Date of Patent: October 7, 2003
    Assignees: Destiny Pharma Limited, University of East Anglia
    Inventors: William Guy Love, Michael John Cook, David Andrew Russell
  • Phospholipid-coated implants
    Publication number: 20020165617
    Abstract: A prosthesis or implant has a surface carrying a coating comprising at least one phospholipid at a concentration to improve osteointegration. A method of making such a prosthesis or implant and a kit comprising a prosthesis or implant is also described.
    Type: Application
    Filed: February 28, 2002
    Publication date: November 7, 2002
    Applicant: DESTINY PHARMA LIMITED
    Inventors: Andrew W. Lloyd, Matteo Santin, Stephen P. Denyer, William Rhys-Williams, William G. Love